Pharmeasy Reports A Record-Setting Positive EBITDA Of Rs 14 Crore: Implications…?
PharmEasy has instilled hope for fundraising and investment with its latest EBITDA reports. The company took significant steps, like delaying its IPO in 2022 and focusing on reducing the cash…
Share